MOH — authorised 1 February 2013
- Marketing authorisation holder: HYPERION THERAP INC
- Status: likely_approved
MOH authorised Ravicti on 1 February 2013
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 1 February 2013.
HYPERION THERAP INC holds the UAE marketing authorisation.